Application of imaging-derived parameters to dosimetry of intravascular brachytherapy sources: Perturbation effects of residual plaque burden

Medical Physics

Volumn 29, Issue 7, 2002, Pages 1580-1589

  Sehgal, Varun ^a   Li, Zuofeng ^a   Palta, Jatinder R ^a   Smith, Karen M ^b   Bolch, W E ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiography; Brachytherapy; Intravascular ultrasound; Radiation dosimetry

Indexed keywords

ANGIOGRAPHY; MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY;

BRACHYTHERAPY; CLINICAL MEASUREMENTS; DERIVED PARAMETERS; INTRAVASCULAR BRACHYTHERAPY; INTRAVASCULAR ULTRASOUND; MATERIAL HETEROGENEITY; PERCUTANEOUS CORONARY INTERVENTION; PERTURBATION EFFECT;

DOSIMETRY;

PHOSPHORUS 32; STRONTIUM 90; YTTRIUM 90; PHOSPHORUS; STRONTIUM; YTTRIUM;

ANGIOGRAPHY; ARTICLE; BRACHYTHERAPY; CORONARY BLOOD VESSEL; DOSE CALCULATION; DOSIMETRY; IMAGE ANALYSIS; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE; HUMAN; IMAGE PROCESSING; METHODOLOGY; RADIOMETRY; THEORETICAL MODEL;

BRACHYTHERAPY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MODELS, THEORETICAL; MONTE CARLO METHOD; PHOSPHORUS RADIOISOTOPES; RADIOMETRY; STRONTIUM RADIOISOTOPES; YTTRIUM RADIOISOTOPES;

EID: 0035996463     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1485053     Document Type: Article

References (29)

1. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT)
2. Endovascular β-radiation to reduce restenosis after coronary balloon angioplasty: Results of the β-energy restenosis trial (BERT)
3. Clinical experience with a spiral balloon centering catheter for the delivery of intracoronary radiation therapy
4. Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial
5. 188Re-Filled Balloon: Six-month results from a clinical safety and feasibility study
6. Prevention of coronary restenosis: The evolving evidence base for radiation therapy
7. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
8. Intracoronary radiation: It keeps on glowing
9. 32P catheter-based vascular brachytherapy source wire
10. Dosimetric perturbations of linear array of β-emitter seeds and metallic stent in intravascular brachytherapy
11. Beta versus gamma for catheter-based intravascular brachytherapy: Dosimetric perspectives in the presence of metallic stents and calcified plaques
12. Dose model for a beta-emitting stent in a realistic artery consisting of soft tissue and plaque
13. Dosimetric effect of source centering and residual plaque for β-emitting catheter based intravascular brachytherapy sources
14. Nonangiographic coronary lesion assessment
15. Calculated dose distributions of beta-particle sources used for intravascular brachytherapy
16. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43
17. Intracoronary radiation therapy dosimetry: A different perspective on β versus γ
18. Active centering is not important for intracoronary radiation therapy
19. Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy
20. Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and β-radiation therapy
21. Safety of intracoronary γ-radiation on uninjured reference segments during the first six months after treatment of in-stent restenosis: A serial intravascular ultrasound study
22. Intracoronary β-radiation therapy inhibits recurrence of in-stent restenosis
23. Comparison of angiography and intravascular ultrasound before and after balloon angioplasty of the femoropopliteal artery
24. Making IVUS easy: Integrating intravascular ultrasound into routine catheterization laboratory practice
25. Measurement of density and calcium in human atherosclerotic plaque and implications for arterial brachytherapy
26. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta
27. Bone morphogenetic protein expression in human atherosclerotic lesions
28. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis